Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual>It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion. Shares of Pfizer rose 2.5% in intraday trading. “The second quarter was remarkable in a number of ways,” Pfizer CEO Albert Bourla said in a statement.
"Or if you have a better explanation of why the interest in myocarditis went up after the vaccine rollout, please let me know in the comments."
Easy!
Because there's so much misinformation making the rounds about this, people start to take an interest!
See, explained that one away for ya.
Also, we need more funding for the 77th Brigade and the Trusted News Initiative.
Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual>It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion. Shares of Pfizer rose 2.5% in intraday trading. “The second quarter was remarkable in a number of ways,” Pfizer CEO Albert Bourla said in a statement.
Are the 3 vaxx companies all owned by jewish folks? Asking for a friend.